These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 27254810)

  • 1. Developing a Very Low Vision Orientation and Mobility Test Battery (O&M-VLV).
    Finger RP; Ayton LN; Deverell L; O'Hare F; McSweeney SC; Luu CD; Fenwick EK; Keeffe JE; Guymer RH; Bentley SA
    Optom Vis Sci; 2016 Sep; 93(9):1127-36. PubMed ID: 27254810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing an instrumental activities of daily living tool as part of the low vision assessment of daily activities protocol.
    Finger RP; McSweeney SC; Deverell L; O'Hare F; Bentley SA; Luu CD; Guymer RH; Ayton LN
    Invest Ophthalmol Vis Sci; 2014 Nov; 55(12):8458-66. PubMed ID: 25425306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing the impact of Vision Impairment-Very Low Vision (IVI-VLV) questionnaire as part of the LoVADA protocol.
    Finger RP; Tellis B; Crewe J; Keeffe JE; Ayton LN; Guymer RH
    Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6150-8. PubMed ID: 25190656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measures of visual function and percentage of preferred walking speed in older adults: the Salisbury Eye Evaluation Project.
    Patel I; Turano KA; Broman AT; Bandeen-Roche K; Muñoz B; West SK
    Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):65-71. PubMed ID: 16384945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orientation and mobility outcome measures.
    Chang KJ; Dillon LL; Deverell L; Boon MY; Keay L
    Clin Exp Optom; 2020 Jul; 103(4):434-448. PubMed ID: 31838758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Visual rehabilitation in patients with retinitis pigmentosa].
    de Castro CT; Berezovsky A; de Castro DD; Salomão SR
    Arq Bras Oftalmol; 2006; 69(5):687-90. PubMed ID: 17187136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of visual field loss and mobility performance in older adults: Salisbury Eye Evaluation Study.
    Turano KA; Broman AT; Bandeen-Roche K; Munoz B; Rubin GS; West S;
    Optom Vis Sci; 2004 May; 81(5):298-307. PubMed ID: 15181354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timed instrumental activities of daily living tasks in adults with irreversible vision impairment: validation to visual function and self-report.
    Balakrishnan P; McGwin G; Owsley C
    BMC Ophthalmol; 2024 Sep; 24(1):417. PubMed ID: 39333971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perceived and actual performance of daily tasks: relationship to visual function tests in individuals with retinitis pigmentosa.
    Szlyk JP; Seiple W; Fishman GA; Alexander KR; Grover S; Mahler CL
    Ophthalmology; 2001 Jan; 108(1):65-75. PubMed ID: 11150266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring outcomes of vision rehabilitation with the Veterans Affairs Low Vision Visual Functioning Questionnaire.
    Stelmack JA; Szlyk JP; Stelmack TR; Demers-Turco P; Williams RT; Moran D; Massof RW
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3253-61. PubMed ID: 16877389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a battery of functional tests for low vision.
    Dougherty BE; Martin SR; Kelly CB; Jones LA; Raasch TW; Bullimore MA
    Optom Vis Sci; 2009 Aug; 86(8):955-63. PubMed ID: 19593240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of a Head-mounted Low Vision Device on Visual Function.
    Wittich W; Lorenzini MC; Markowitz SN; Tolentino M; Gartner SA; Goldstein JE; Dagnelie G
    Optom Vis Sci; 2018 Sep; 95(9):774-784. PubMed ID: 30153237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visual function, visual attention, and mobility performance in low vision.
    Leat SJ; Lovie-Kitchin JE
    Optom Vis Sci; 2008 Nov; 85(11):1049-56. PubMed ID: 18981920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guidelines for predicting performance with low vision AIDS.
    Latham K; Tabrett DR
    Optom Vis Sci; 2012 Sep; 89(9):1316-26. PubMed ID: 22926113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing self-reported vision-related activity limitation in the visually impaired.
    Tabrett DR; Latham K
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5293-302. PubMed ID: 21613370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mental effort required for walking: effects of retinitis pigmentosa.
    Turano KA; Geruschat DR; Stahl JW
    Optom Vis Sci; 1998 Dec; 75(12):879-86. PubMed ID: 9875993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards an assistive peripheral visual prosthesis for long-term treatment of retinitis pigmentosa: evaluating mobility performance in immersive simulations.
    Zapf MP; Boon MY; Matteucci PB; Lovell NH; Suaning GJ
    J Neural Eng; 2015 Jun; 12(3):036001. PubMed ID: 25782059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orientation and mobility assessment in retinal prosthetic clinical trials.
    Geruschat DR; Bittner AK; Dagnelie G
    Optom Vis Sci; 2012 Sep; 89(9):1308-15. PubMed ID: 22902422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefit of an electronic head-mounted low vision aid.
    Crossland MD; Starke SD; Imielski P; Wolffsohn JS; Webster AR
    Ophthalmic Physiol Opt; 2019 Nov; 39(6):422-431. PubMed ID: 31696539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring mobility performance: experience gained in designing a mobility course.
    Leat SJ; Lovie-Kitchin JE
    Clin Exp Optom; 2006 Jul; 89(4):215-28. PubMed ID: 16776729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.